Cargando…
Single-dose prophylactic ibuprofen therapy for patent ductus arteriosus in preterm infants
This study aimed to evaluate the short-term morbidities and efficacy of single-dose prophylactic intravenous ibuprofen for patent ductus arteriosus (PDA) on the first day of life in preterm infants. Data of 69 preterm infants with birth weight < 1250 g and gestational age < 30 weeks admitted t...
Autores principales: | Kim, Chae Young, Chung, Sung-Hoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351839/ https://www.ncbi.nlm.nih.gov/pubmed/35945745 http://dx.doi.org/10.1097/MD.0000000000029915 |
Ejemplares similares
-
Comparison of the Mortality and In-Hospital Outcomes of Preterm Infants Treated with Ibuprofen for Patent Ductus Arteriosus with or without Clinical Symptoms Attributable to the Patent Ductus Arteriosus at the Time of Ibuprofen Treatment
por: Yoo, Hani, et al.
Publicado: (2017) -
Effects of prophylactic oral ibuprofen on the closure rate of patent ductus arteriosus in premature infants
por: Ding, Yanjie, et al.
Publicado: (2018) -
The Effect of Ibuprofen Exposure and Patient Characteristics on the Closure of the Patent Ductus Arteriosus in Preterm Infants
por: Engbers, Aline G. J., et al.
Publicado: (2022) -
Simulation-based suggestions to improve ibuprofen dosing for patent ductus arteriosus in preterm newborns
por: Flint, Robert B., et al.
Publicado: (2018) -
Enantiomer specific pharmacokinetics of ibuprofen in preterm neonates with patent ductus arteriosus
por: Engbers, Aline G.J., et al.
Publicado: (2020)